288 related articles for article (PubMed ID: 7745833)
1. [Studies on the blood coagulation factor XIII in patients with increased levels of FDP D-dimer].
Okumura N; Matsuzawa A; Terasawa F; Kameko M; Sasaki Y; Nakagoshi R; Ishikawa S; Hashikura Y; Matsunami H; Kawasaki S
Rinsho Byori; 1995 Mar; 43(3):269-74. PubMed ID: 7745833
[TBL] [Abstract][Full Text] [Related]
2. [Changes in coagulation parameters during the clinical courses of recipients of living-related partial liver transplantation].
Okumura N; Matsuzawa A; Terasawa F; Sasaki Y; Nakagoshi R; Ishikawa S; Hashikura Y; Matsunami H; Kawasaki S; Makuuchi M
Rinsho Byori; 1995 Aug; 43(8):829-35. PubMed ID: 7474443
[TBL] [Abstract][Full Text] [Related]
3. [Clinical application of laboratory diagnosis: leukemia and DIC].
Deguchi K; Zhao LJ; Shirakawa S
Rinsho Byori; 1991 Jul; 39(7):736-42. PubMed ID: 1833571
[TBL] [Abstract][Full Text] [Related]
4. Hemostatic molecular markers before onset of disseminated intravascular coagulation in leukemic patients.
Wada H; Sakuragawa N; Shiku H
Semin Thromb Hemost; 1998; 24(3):293-7. PubMed ID: 9701463
[TBL] [Abstract][Full Text] [Related]
5. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
[TBL] [Abstract][Full Text] [Related]
6. [Studies on the fragments of FDP in 4 patients with DIC].
Okumura N; Furuwatari C; Ishikawa S; Furihata K; Katsuyama T; Kanai M; Nakahata T; Saitoh H
Rinsho Byori; 1992 Oct; 40(10):1089-95. PubMed ID: 1307614
[TBL] [Abstract][Full Text] [Related]
7. [Studies on the fragments of FDP in 3 patients with DIC associated with acute promyelocytic leukemia].
Okumura N; Furuwatari C; Ishikawa S; Furihata K; Katsuyama T; Kanai M; Nakahata T; Saitoh H
Rinsho Byori; 1993 Jun; 41(6):719-25. PubMed ID: 8361040
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis of pre-disseminated intravascular coagulation stage with hemostatic molecular markers. The Mie DIC Study Group.
Wada H; Wakita Y; Nakase T; Shimura M; Hiyoyama K; Nagaya S; Mori Y; Deguchi K; Shiku H
Pol J Pharmacol; 1996; 48(2):225-8. PubMed ID: 9112656
[TBL] [Abstract][Full Text] [Related]
9. Outcome of disseminated intravascular coagulation in relation to the score when treatment was begun. Mie DIC Study Group.
Wada H; Wakita Y; Nakase T; Shimura M; Hiyoyama K; Nagaya S; Mori Y; Shiku H
Thromb Haemost; 1995 Sep; 74(3):848-52. PubMed ID: 8571309
[TBL] [Abstract][Full Text] [Related]
10. Incidence and clinical significance of elevated fibrin(ogen) degradation product and/or D-dimer levels in liver cirrhosis patients.
Cioni G; Cristani A; Mussini C; Grandi S; Pentore R; Zeneroli ML; Tizzanini W; Zagni G; Ventura E
Ital J Gastroenterol; 1990 Apr; 22(2):70-4. PubMed ID: 2131934
[TBL] [Abstract][Full Text] [Related]
11. Determination of plasma soluble fibrin using a new ELISA method in patients with disseminated intravascular coagulation.
Okajima K; Uchiba M; Murakami K; Okabe H; Takatsuki K
Am J Hematol; 1996 Mar; 51(3):186-91. PubMed ID: 8619398
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of cross-linked fibrin and fibrinogen degradation products with SDS-PAGE and immunoblot].
Okumura N; Kagiya H; Kumagai T; Kameko M; Tozuka M; Saito H; Katsuyama T; Kanai M
Rinsho Byori; 1990 Feb; 38(2):201-7. PubMed ID: 2329722
[TBL] [Abstract][Full Text] [Related]
13. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
Koga S
Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
[TBL] [Abstract][Full Text] [Related]
14. [Hemostatic changes before and after the onset of disseminated intravascular coagulation].
Wada H; Tanigawa M; Takagi M; Suzuki H; Mori Y; Ohta T; Kobayashi T; Kita K; Tanaka I; Yamaguchi T
Rinsho Ketsueki; 1989 Oct; 30(10):1755-62. PubMed ID: 2593241
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of clinical usefulness of a rapid quantitative measurement of D dimer (cross-linked fibrin degradation products)].
Takahashi H; Wada K; Takizawa S; Sakurai G; Hanano M; Niwano H; Tatewaki W; Shibata A
Rinsho Ketsueki; 1991 Dec; 32(12):1533-9. PubMed ID: 1779452
[TBL] [Abstract][Full Text] [Related]
16. [Clinical evaluation of a test for plasma fibrin/fibrinogen degradation products (FDP) based on monoclonal anti-FDP antibody technology: an application for the scoring system of the disseminated intravascular coagulation (DIC) diagnostic criteria].
Ito K; Wada H; Abe Y; Tomatsu H; Nishioka J; Nobori T
Rinsho Byori; 2003 Apr; 51(4):295-9. PubMed ID: 12747249
[TBL] [Abstract][Full Text] [Related]
17. [Coagulation tests in septic surgical patients].
Oberhofer D; Kucisec-Tepes N; Skok J; Vucić N; Cala K
Acta Med Croatica; 2004; 58(5):389-94. PubMed ID: 15756805
[TBL] [Abstract][Full Text] [Related]
18. [Molecular marker for detecting hypercoagulable state].
Magari Y; Mizunaga S; Ito M; Shibata T; Ito H
Rinsho Byori; 1994 Jan; 42(1):22-33. PubMed ID: 8107279
[TBL] [Abstract][Full Text] [Related]
19. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T
Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260
[TBL] [Abstract][Full Text] [Related]
20. [Study on cases of D dimer values were dissociated from FDP-E].
Himizu M; Ishii K; Katagiri H; Saga K; Ono F; Yamamoto M; Todoroki T; Kawai Y; Watanabe K; Iri H
Rinsho Byori; 1991 Mar; 39(3):302-8. PubMed ID: 2051606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]